Anzeige
Mehr »
Login
Donnerstag, 07.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus“ in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 897517 | ISIN: IL0010826357 | Ticker-Symbol: NUR
Frankfurt
06.11.24
15:29 Uhr
12,000 Euro
-0,100
-0,83 %
1-Jahres-Chart
ELLOMAY CAPITAL LTD Chart 1 Jahr
5-Tage-Chart
ELLOMAY CAPITAL LTD 5-Tage-Chart
RealtimeGeldBriefZeit
11,90014,40006.11.
PR Newswire
893 Leser
Artikel bewerten:
(2)

Ellomay Capital Ltd.: Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2023

TEL-AVIV, Israel, March 31, 2024 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited financial results for the fourth quarter and year ended December 31, 2023.

Financial Highlights

• Total assets as of December 31, 2023 amounted to approximately €611.7 million, compared to total assets as of December 31, 2022 of approximately €576.2 million.

• Revenues1 for the three months ended December 31, 2023 and 2022 were approximately €8.4 million. Revenues for the year ended December 31, 2023, were approximately €48.8 million, compared to approximately €52.2 million for the year ended December 31, 2022.

• Loss for the three months ended December 31, 2023 was approximately €9.8 million, compared to a profit of approximately €2.5 million for the three months ended December 31, 2022. Profit for the year ended December 31, 2023, was approximately €0.6 million, compared with approximately €0.1 million for the year ended December 31, 2022.

• EBITDA loss for the three months ended December 31, 2023 was approximately €2.5 million, compared to EBITDA of approximately €1.7 million for the three months ended December 31, 2022. EBITDA for the year ended December 31, 2023 was approximately €18.8 million, compared to approximately €20.8 million for the year ended December 31, 2022. See below under "Use of Non-IFRS Financial Measures" for additional disclosure concerning EBITDA.

• On December 31, 2023, the Company executed an agreement to sell its holdings in the 9 MW PV plant located in Talmei Yosef, Israel in consideration for NIS 44.75 million (approximately €11.2 million), with an additional potential payment of up to NIS 4 million in the event the Talmei Yosef PV Plant produces more than 18 million Kwh during 2024. In connection with the expected sale, the Company presents the results of this PV plant as discontinued operations and the results for the year and for the three months ended December 31, 2022 are adjusted accordingly. See below for additional information.

Financial Overview for the Year Ended December 31, 2023

• Revenues were approximately €48.8 million for the year ended December 31, 2023, compared to approximately €52.2 million for the year ended December 31, 2022. The decrease in revenues mainly results from the decrease in electricity prices in Spain and from a curtailment of the electricity supply from the Company's facilities in Spain to the grid during June 2023 due to maintenance and upgrade work on the main transmission line between Spain and Portugal, which caused a decrease in revenues of approximately €1 million. The Company subsequently implemented a solution aimed at minimizing the impact of future similar curtailments due to maintenance and upgrades to the national grid. The decrease in revenues was partially offset by an increase in revenues from the Company's biogas plants in the Netherlands, resulting mainly from increased production and an increase in the 2023 gas price, and from the connection to the grid of Ellomay Solar (a 28 MW photovoltaic plant in Spain) during June 2022, upon which the Company commenced recognition of revenues.

• Operating expenses were approximately €22.9 million for the year ended December 31, 2023, compared to approximately €23.7 million for the year ended December 31, 2022. The decrease in operating expenses mainly results from a decrease in payments under the Spanish RDL 17/2022, caused by a reduction in the electricity market price. RDL 17/2022 established the reduction of returns on the electricity generating activity of Spanish production facilities that do not emit greenhouse gases, accomplished through payments of a portion of the revenues by the production facilities to the Spanish government. As a result of the decrease in the electricity market price in Spain during the year ended December 31, 2023, the payments under RDL 17/2022 were lower compared to last year. This decrease in operating expenses was partially offset by increased operating expenses in connection with the Company's biogas operations in the Netherlands caused by higher production and the use of higher quality raw materials, and from the connection to the grid of Ellomay Solar during June 2022, upon which the Company commenced recognition of expenses. Depreciation and amortization expenses were approximately €16 million for the year ended December 31, 2023, compared to approximately €15.6 million for the year ended December 31, 2022. The increase in depreciation and amortization expenses is mainly attributable to the commencement of recognition of results of Ellomay Solar upon connection to the Spanish grid in June 2022.

• Project development costs were approximately €4.5 million for the year ended December 31, 2023, compared to approximately €3.8 million for the year ended December 31, 2022. The increase in project development costs is mainly due to development expenses in connection with photovoltaic projects in the USA, Italy, and Israel.

• General and administrative expenses were approximately €5.3 million for the year ended December 31, 2023, compared to approximately €5.9 million for the year ended December 31, 2022. The decrease in general and administrative expenses is mostly due to a decrease in D&O liability insurance costs and to bonuses paid to employees in 2022.

• The Company's share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €4.3 million for the year ended December 31, 2023, compared to approximately €1.2 million for the year ended December 31, 2022. The increase in share of profits of equity accounted investee was mainly due to the increase in revenues of Dorad Energy Ltd. ("Dorad") due to higher quantities produced and a higher electricity tariff, partially offset by an increase in operating expenses in connection with the increased production and higher tariff.

• Financing expenses, net, were approximately €3.6 million for the year ended December 31, 2023, compared to approximately €3.5 million for the year ended December 31, 2022. The increase in financing expenses, net, was mainly attributable to higher interest expenses in connection with the Company's loans (net of any related SWAP payments) and debentures amounting to an aggregate amount of approximately €11.6 million in the year ended December 31, 2023, compared to approximately €9.2 million for the year ended December 31, 2022. The increase in interest expenses mainly resulted from the issuance of the Company's Series E debentures in February 2023 and from higher interest rates applied to variable interest rate bearing loans. This increase was partially offset by higher interest income due to increased interest rates amounting to approximately €2 million in the year ended December 31, 2023, compared to an amount of approximately €0.3 million for the year ended December 31, 2022, and to higher income resulting from exchange rate differences, of approximately €6.7 million in the year ended December 31, 2023, mainly in connection with the New Israeli Shekel ("NIS") cash and cash equivalents and the Company's NIS denominated debentures, compared to approximately €6 million for the year ended December 31, 2022, caused by the 6.9% devaluation of the NIS against the euro during the year ended December 31, 2023, compared to a 6.6% appreciation of the NIS against the euro during the year ended December 31, 2022.

• Tax benefit was approximately €1.4 million in the year ended December 31, 2023, compared to taxes on income of approximately €1.7 million in the year ended December 31, 2022. The change in tax is mainly due to the substantial decrease in electricity prices in Spain, resulting in lower taxable income of the Company's Spanish subsidiaries.

• Loss from discontinued operations (net of tax) was approximately €1.8 million in the year ended December 31, 2023, compared to a profit from discontinued operations of approximately €0.7 million in the year ended December 31, 2022.

On December 31, 2023, the Company executed an agreement to sell its holdings in the 9 MW PV plant located in Talmei Yosef, Israel (the "Agreement" and the "Talmei Yosef PV Plant," respectively). The Agreement provides for the sale of the Company's holdings in the Talmei Yosef PV Plant to Greenlight Fund Limited Partnership and Doral Group Renewable Energy Resources Ltd., in equal parts, in consideration for NIS 44.75 million (approximately €11.2 million), with an additional potential payment of up to NIS 4 million in the event the Talmei Yosef PV Plant produces more than 18 million Kwh during 2024. The Agreement further provides for a cutoff date of June 30, 2023, and at closing the parties will determine whether an adjustment to the purchase price is required reflect the Company's entitlement to revenues (net of expenses) up to such date, taking into account the results and the cash held by the project company. The Company does not expect a material adjustment to the purchase price.

In connection with the expected sale of the Talmei Yosef PV Plant, the Company presents the results of the Talmei Yosef PV Plant as discontinued operations and the results for the year and for the three months ended December 31, 2022 are adjusted accordingly. The Talmei Yosef PV Plant is presented in the Company's financial results as a financial asset, in accordance with IFRIC 12 under IFRS, and since its acquisition of the plant, the Company recognized relatively high profits through its ownership. Accordingly, although the consideration expected to be received for the Talmei Yosef PV Plant reflects a market value that is higher than the price invested by the Company in its acquisition, due to the accounting treatment under IFRIC 12, the Company recognized a net loss of approximately €1.8 million in connection with the expected sale.

The Agreement includes customary representations and indemnification undertakings in connection with breaches of representations, which, other than with respect to customary exceptions, are subject to a cap of NIS 9 million and limited to a period of 18 months from the closing date. The consummation of the sale is subject to various customary conditions to closing, including receipt of regulatory approvals and the consent of the financing entity of the Talmei Yosef PV Plant. All conditions to closing are required to be fulfilled within an initial period of 90 days from execution of the Talmei Yosef Sale Agreement, which can be extended to up to 150 days under certain circumstances. The Talmei Yosef PV Plant is located in southern Israel. One of the conditions to closing is the end of the "war" status in southern Israel for a pre-determined period (based on the official definitions published by the Israeli Authorities) and that the Talmei Yosef PV Plant is physically accessible. Based on the circumstances as of the date hereof, this condition is currently fulfilled but there can be no assurance that it will continue to be fulfilled on the expected closing date. The closing of the sale is currently expected during the second quarter of 2024. The Talmei Yosef Sale Agreement further provides that in the event that due to the current war and hostilities in Israel the facility will be damaged or its output will decrease, the buyers will have the right not to consummate the acquisition of the plant. The consummation of the transactions contemplated by the Agreement is subject to the fulfilment of the conditions to closing as of the date of the closing. These conditions to closing are mostly not within the Company's control or the buyers' control. There can be no assurance as to whether or when the conditions to closing will be satisfied and as to the impact of the war and hostilities in Israel on the ability to consummate the sale and on the final purchase price.

• Net profit was approximately €0.6 million in the year ended December 31, 2023, compared to approximately €0.1 million in the year ended December 31, 2022.

• Total other comprehensive income was approximately €41.3 million for the year ended December 31, 2023, compared to total other comprehensive loss of approximately €35.3 million in the year ended December 31, 2022. The change in total other comprehensive loss mainly results from changes in fair value of cash flow hedges, including a material increase in the fair value of the liability resulting from the financial power swap that covers approximately 80% of the output of the Talasol PV Plant (the "Talasol PPA").

The Talasol PPA experienced a high volatility due to the substantial change in electricity prices in Europe. In accordance with hedge accounting standards, the changes in the Talasol PPA's fair value are recorded in the Company's shareholders' equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company's consolidated net profit/loss or the Company's consolidated cash flows.

• Total comprehensive income was approximately €41.9 million in the year ended December 31, 2023, compared to total comprehensive loss of approximately €35.2 million in the year ended December 31, 2022.

• EBITDA was approximately €18.8 million for the year ended December 31, 2023, compared to approximately €20.8 million for the year ended December 31, 2022.

• Net cash from operating activities was approximately €9.7 million for the year ended December 31, 2023, compared to approximately €11.3 million for the year ended December 31, 2022.

CEO Review Fourth Quarter and Full Year 2023

2023 was characterized by a decline in the electricity prices in Europe compared to the prices in 2022. The decrease is mainly evident in Spain, whereas in Italy the prices remained relatively stable. Despite the significant decrease in electricity prices in Spain, the revenues for 2023 did not decrease in the same rate and were approximately €48.8 million, compared to revenues of approximately €52.2 million in 2022. The main reason that the significant decrease in electricity prices in Spain has a relatively small impact on the Company's revenues is that the majority of the electricity the Company sells in Spain is under a long-term PPA. Net profit for 2023 was approximately €0.6 million, compared to approximately €0.1 million for 2022. The EBITDA for 2023 was approximately €18.8 million, compared to EBITDA of approximately €20.8 million in 2022. The decrease in the EBIDTA for 2023 was mainly due to a loss from discontinued operations in the amount of approximately €1.8 million that was recorded in connection with the expected sale of the Talmei Yosef facility. Although the consideration expected to be received for the Talmei Yosef project reflects a market value that is higher than the price invested by the Company in its acquisition, because the Talmei Yosef facility is treated as financial asset under IFRIC 12, the Company recorded a loss in connection with the expected sale.

The Dorad power station presented an increase in revenues and net income during 2023, and the net income of Dorad for 2023 was approximately €53 million.

The development and construction activities of solar projects in the USA are advancing rapidly and the construction of the first two projects, with an aggregate capacity of approximately 27.5 MW, commenced in early 2024. Two additional projects with an aggregate capacity of approximately 22 MW are expected to commence construction in May 2024 and additional projects scheduled for construction in 2025 are under development.

In Italy, the construction of a solar project with a capacity of 18 MW (ELLO 10) commenced, in addition to solar projects with a capacity of approximately 20 MW who have finished construction. Of the 20 MW that have finished construction, 5 MW were connected to the grid during the first quarter of 2024 and an additional 15 MW are expected to connect to the grid shortly. Therefore, the additional income from sales of electricity in Italy will only be reflected in 2024.

At the end of 2023 an agreement for the sale of the Talmei Yosef PV project was executed, the cutoff date for the transaction was set at June 30, 2023. The Company maintained the rights to a portion of the land in Talmei Yosef, which will be used to construct projects under development (the Talmei Yosef Project and the Talmei Yosef Storage Project in Batteries noted below) that are currently not recorded as fixed assets in the Company's financial statements. Due to the expected sale, the financial results of the Talmei Yosef PV plant are presented as discontinued operations in the Company's financial results for 2023.

The Company's operations concentrate on three main fields:

- Construction of New Projects: solar projects in the USA, solar projects in Italy, and a pumped hydro storage project in the Manara Cliff in Israel.

- Initiating and Developing of New Projects: solar projects in Italy, Spain, USA and Israel.

- Management, Operation and Improvement of Generating Projects: in Israel (solar), Spain (solar) and the Netherlands (bio-gas).

Activity in Spain :

During 2023, the Talasol solar project (300 MW, Company's share is 51%) produced revenues from the sale of electricity and green certificates of approximately €25 million, slightly below the expected revenues due to a maintenance event in the main distribution line that caused a loss of revenues of approximately €1 million. As a result of the event a system was installed that significantly limits the possibility that such an event will recur in the future. Talasol is a party to a financial hedge of its electricity capture price (PPA). Approximately 80% of its production (75% based on P-50) are sold under this agreement for a fixed price. The remaining electricity produced by Talasol is sold directly to the grid, at spot prices.

During 2023, the Ellomay Solar project (28 MW) produced revenues from the sale of electricity and green certificates of approximately €4 million.

Activity in Italy :

The Company has approximately 505 solar MW projects under advanced development stages, of which licenses have been obtained for approximately 203 MW. Projects with an aggregate capacity of approximately 20 MW have finished construction, of which 5 MW was connected during the first quarter of 2024 and an additional 15 MW will be connected within a few weeks. The construction works of ELLO 10 (18 MW) commenced and the completion of the construction is expected in the third quarter of 2024.

Activity in Israel :

The Manara Pumped Storage Project (Company's share is 83.34%): The Manara Cliff pumped storage project, with a capacity of 156 MW, is in advanced construction stages. The Iron Swords War, which commenced on October 7, 2023, stopped the construction work on the project. The project has protection from the state for damages and losses due to the war within the framework of the tariff regulation (covenants that support financing). The project was expected to reach commercial operation during the first half of 2027 and the continuation of the Iron Swords war will case a delay in the date of operations. The Israeli Electricity Authority currently approved a postponement of eight months of the dates for the project. The Company and its partner in the project, Ampa, invested the equity required for the project (other than linkage differences), and the remainder of the funding is from a consortium of lenders led by Mizrahi Bank, at a scope of approximately NIS 1.18 billion.

Development of Solar licenses combined with storage:

1.The Komemiyut Project: intended for 21 solar MW and 50 MW / hour batteries. The sale of electricity will be conducted through a private supplier. Commencement of construction is planned for the third quarter of 2024.

2.The Qelahim Project: intended for 21 solar MW and 50 MW / hour batteries. The sale of electricity will be conducted through a private supplier. Commencement of construction is planned for the fourth quarter of 2024.

With respect to projects 1 and 2, the Company waived the rights it won in the tender process no. 1 for battery storage and elected to transition to the regulation that enables direct sale to end customers.

3.The Talmei Yosef Project: intended for 10 solar MW and 22 MW / hour batteries. The request for zoning approval was approved in the fourth quarter of 2023.

4.The Talmei Yosef Storage Project in Batteries: there is a zoning approval for approximately 400 MW / hour. The project is designed for the regulation of high voltage storage.

5. The Company also has approximately 46 solar MW under preliminary planning stages.

Dorad Power Station (Company's share is approximately 9.4%): the gas flow from the Karish reservoir that began in November 2022 reduced the gas costs of Dorad. Dorad benefited from the increase in the TAOZ and the production component compared to the same period last year. In addition, the Israeli Electricity Authority's resolution in connection with the changes of the hourly tariffs, which entered into force in January 2023, means an extension of the "summer" period (a month was added to the "summer" season in which the tariffs are higher), the elimination of the "GEVA" (average consumption) hours and the change in the "PISGA" (peak) hours in the intermediate seasons to the afternoon and evening. As a result, Dorad provides availability to the system manager for the "SHEFEL" (low) period, which is longer and the demand of the system manager is higher. As a result of the continuous operations of the power plant, the maintenance expenses decreased and the hours of operation increased, increasing production and the revenues and profit. Moreover, the Israeli government decided to increase the power station by an additional 650 MW and the National Infrastructure Committee approved the TTL/11/B plan - expansion of the Dorad power station.

In June 2023, an arbitration award was given that, among other issues, obligated Zorlu and Edeltech to refund approximately $130 million to Dorad and to pay the derivative plaintiffs NIS 20 million as reimbursement of legal expenses. Appeals on the arbitration award were submitted by both parties and the appeal process was agreed in advance and is expected to end in the second quarter of 2024.

Activity in the Netherlands :

In connection with the military conflict in Ukraine and the stoppage of Russian gas supply to Europe, there are substantial changes in the field of biogas in the Netherlands and Europe. Europe in general and the Netherlands specifically have set ambitious goals for increasing gas production from waste. Various incentives are being considered, the main one is increasing the price of the green certificates. The price of these certificates has increased from approximately 13-15 euro cents per cubic meter to around 45 euro cents per cubic meter. The prices of green certificates continue to rise and the expectation is that the price will reach approximately 60 euro cents per cubic meter in 2024.

The Company estimates that with the increasing importance of the biogas field, this field entered into a new era. In the Netherlands, new legislation was adopted that obliges the gas suppliers to incorporate green gas in a scope of up to 20% of the amount supplied by them, valid commencing January 1, 2025. This legislation and the growing demand for green certificates derived from the biogas industry, is expected to add and significantly improve the results of the biogas segment of the Company.

Activity in Texas, USA:

During the first quarter of 2024, the construction of the initial two projects, with an aggregate installed capacity of approximately 27.5 MW DC commenced, expected completion date is in September 2024. Two additional projects with an aggregate installed capacity of approximately 22 MW DC are expected to commence construction in May 2024. The estimated capital cost for the first two projects is approximately $30 - $32 million, of which the Company's share is expected to be approximately $19 - $21 million. The estimated capital cost for the two additional projects is approximately $24 - $26 million, of which the Company's share is expected to be $15 - $17 million. The remaining capital costs are expected to be covered by tax equity partners. The Company is developing additional projects scheduled for construction in 2025.

Use of Non-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 19 of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe, the USA and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

• Approximately 35.9 MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;

• 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 850MW;

• 51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;

• Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million Nm3 per year, respectively;

• 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;

• Ellomay Solar Italy One SRL and Ellomay Solar Italy Two SRL that are constructing photovoltaic plants with installed capacity of 14.8 MW and 4.95 MW, respectively, in the Lazio Region, Italy;

• Ellomay Solar Italy Four SRL, Ellomay Solar Italy Five SRL, Ellomay Solar Italy Seven SRL, Ellomay Solar Italy Nine SRL and Ellomay Solar Italy Ten SRL that are developing photovoltaic projects with installed capacity of 15.06 MW, 87.2 MW, 54.77 MW, 8 MW and 18 MW, respectively, in Italy that have reached "ready to build" status; and

• Fairfield Solar Project, LLC, Malakoff Solar I, LLC, Malakoff Solar II, LLC, Mexia Solar I, LLC, Mexia Solar II, LLC, and Talco Solar, LLC, that are developing photovoltaic projects with installed capacity of 13.44 MW, 6.96 MW, 6.96 MW, 5.2 MW, 5.2 MW and 9.7 MW respectively, in the Dallas Metropolitan area, Texas, and have reached "ready to build" status.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "will," "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including changes in electricity prices and demand, regulatory changes, the impact of the war and hostilities in Israel and Gaza, increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, the impact of the continued military conflict between Russia and Ukraine, technical and other disruptions in the operations or construction of the power plants owned by the Company and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Kalia Rubenbach (Weintraub)
CFO
Tel: +972 (3) 797-1111
Email: [email protected]

Ellomay Capital Ltd. and Its Subsidiaries

Condensed Consolidated Statements of Financial Position



December 31,

2023

2022

2023

Unaudited

Audited

Unaudited

€ in thousands

Convenience Translation
into US$ in thousands*

Assets




Current assets:




Cash and cash equivalents

51,127

46,458

56,548

Marketable securities

-

2,836

-

Short term deposits

997

-

1,103

Restricted cash

810

900

896

Receivable from concession project

-

1,799

-

Intangible asset from green certificates

553

585

612

Trade and other receivables

11,992

12,097

13,264

Assets of disposal groups classified as held for sale

28,297

-

31,298


93,776

64,675

103,721

Non-current assets




Investment in equity accounted investee

31,772

30,029

35,141

Advances on account of investments

898

2,328

993

Receivable from concession project

-

24,795

-

Fixed assets

407,982

365,756

451,244

Right-of-use asset

30,967

30,020

34,251

Intangible asset

-

4,094

-

Restricted cash and deposits

17,386

20,192

19,230

Deferred tax

8,677

23,510

9,597

Long term receivables

10,446

9,270

11,554

Derivatives

10,948

1,488

12,109


519,076

511,482

574,119





Total assets

612,852

576,157

677,840





Liabilities and Equity




Current liabilities




Current maturities of long-term bank loans

9,784

12,815

10,821

Current maturities of long-term loans

5,000

10,000

5,530

Current maturities of debentures

35,200

18,714

38,933

Trade payables

5,249

4,504

5,808

Other payables

10,859

11,207

12,010

Current maturities of derivatives

4,643

33,183

5,135

Current maturities of lease liabilities

700

745

774

Liabilities of disposal groups classified as held for sale

17,142

-

18,960


88,577

91,168

97,971

Non-current liabilities




Long-term lease liabilities

23,680

22,005

26,191

Long-term loans

237,781

229,466

262,995

Other long-term bank loans

29,373

21,582

32,488

Debentures

104,887

91,714

116,009

Deferred tax

2,516

6,770

2,783

Other long-term liabilities

939

2,021

1,039

Derivatives

-

28,354

-


399,176

401,912

441,505

Total liabilities

487,753

493,080

539,476

Equity




Share capital

25,613

25,613

28,329

Share premium

86,159

86,038

95,295

Treasury shares

(1,736)

(1,736)

(1,920)

Transaction reserve with non-controlling Interests

5,697

5,697

6,301

Reserves

4,299

(12,632)

4,755

Accumulated deficit

(5,037)

(7,256)

(5,571)

Total equity attributed to shareholders of the Company

114,995

95,724

127,189

Non-Controlling Interest

10,104

(12,647)

11,175

Total equity

125,099

83,077

138,364

Total liabilities and equity

612,852

576,157

677,840

* Convenience translation into US$ (exchange rate as at December 31, 20 2 3: euro 1 = US$ 1.106)

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss)


For the three months
ended December 31,

For the year

ended December 31,

For the three months
ended December 31,

For the year
ended December 31,

2023

2022

2023

2022

2023

2023

Unaudited

Unaudited

Audited

Unaudited

in thousands (except per share data)

Convenience Translation into US$*

Revenues

8,424

**8,398

48,834

**52,241

9,317

54,012

Operating expenses

(5,460)

**(5,568)

(22,861)

**(23,671)

(6,039)

(25,285)

Depreciation and amortization expenses

(4,265)

**(4,115)

(16,012)

**(15,580)

(4,717)

(17,710)

Gross profit (loss)

(1,301)

(1,285)

9,961

12,990

(1,439)

11,017








Project development costs

(2,025)

(1,104)

(4,465)

(3,784)

(2,240)

(4,938)

General and administrative expenses

(1,202)

**(916)

(5,283)

**(5,855)

(1,329)

(5,843)

Share of profits of equity accounted investee

(279)

650

4,320

1,206

(309)

4,778

Operating profit (loss)

(4,807)

(2,655)

4,533

4,557

(5,317)

5,014








Financing income

345

**8,295

8,747

**6,443

382

9,675

Financing income (expenses) in connection with derivatives and warrants, net

336

(410)

251

605

372

278

Financing expenses in connection with projects finance

(1,465)

**(1,579)

(6,077)

**(6,008)

(1,620)

(6,721)

Financing expenses in connection with debentures

(1,008)

(799)

(3,876)

(2,130)

(1,115)

(4,287)

Interest expenses on minority shareholder loan

(541)

(306)

(2,014)

(1,529)

(598)

(2,228)

Other financing expenses

(1,499)

**(203)

(588)

**(857)

(1,658)

(650)

Financing income (expenses), net

(3,832)

4,998

(3,557)

(3,476)

(4,237)

(3,933)

Profit (loss) before taxes on income

(8,639)

2,343

976

1,081

(9,554)

1,081

Tax benefit (taxes on income)

799

**(95)

1,436

**(1,652)

884

1,588

Profit (loss) from continuing operations

(7,840)

2,248

2,412

(571)

(8,670)

2,669

Profit (loss) from discontinued operations (net of tax)

(1,975)

**228

(1,787)

**711

(2,184)

(1,976)

Profit (loss) for the period

(9,815)

2,476

625

140

(10,854)

693

Profit (loss) attributable to:







Owners of the Company

(8,490)

3,429

2,219

(357)

(9,390)

2,456

Non-controlling interests

(1,325)

(953)

(1,594)

497

(1,464)

(1,763)

Profit (loss) for the period

(9,815)

2,476

625

140

(10,854)

693

* Convenience translation into US$ (exchange rate as at December 31, 2023: euro 1 = US$ 1.106)

** The results of the Talmei Yosef PV Plant have been reclassified as discontinued operations and the results for these periods have been adjusted accordingly.

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss) (con't)



For the three months
ended December 31,

For the year

ended December 31,

For the three months
ended December 31,

For the year ended
December 31,

2023

2022

2023

2022

2023

2023

Unaudited

Unaudited

Audited

Unaudited

in thousands (except per share data)

Convenience Translation
into US$*

Other comprehensive income (loss) items







That after initial recognition in comprehensive income
(loss) were or will be transferred to profit or loss:







Foreign currency translation differences for foreign operations

1,234

(9,035)

(7,949)

(7,829)

1,365

(8,792)

Effective portion of change in fair value of cash flow hedges

9,409

38,656

59,558

8,976

10,407

65,873

Net change in fair value of cash flow hedges

transferred to profit or loss

(944)

(3,118)

(10,333)

(36,438)

(1,044)

(11,429)

Total other comprehensive income (loss)

9,699

26,503

41,276

(35,291)

10,728

45,652








Total other comprehensive income (loss) attributable to:







Owners of the Company

5,172

9,582

16,931

(19,920)

5,721

18,726

Non-controlling interests

4,527

16,921

24,345

(15,371)

5,007

26,926

Total other comprehensive income (loss)

9,699

26,503

41,276

(35,291)

10,728

45,652

Total comprehensive income (loss) for the period

(116)

28,979

41,901

(35,151)

(126)

46,345








Total comprehensive income (loss) for the period attributable to:







Owners of the Company

(3,318)

13,011

19,150

(20,277)

(3,669)

21,182

Non-controlling interests

3,202

15,968

22,751

(14,874)

3,543

25,163

Total comprehensive income (loss) for the period

(116)

28,979

41,901

(35,151)

(126)

46,345

Basic profit (loss) per share

(0.66)

0.27

0.17

(0.03)

(0.73)

0.19

Diluted profit (loss) per share

(0.66)

0.27

0.17

(0.03)

(0.73)

0.19








Basic profit (loss) per share continuing operations

(0.51)

0.25

0.31

(0.08)

(0.56)

0.34

Diluted profit (loss) per share continuing operations

(0.51)

0.25

0.31

(0.08)

(0.56)

0.34








Basic profit (loss) per share discontinued operations

(0.15)

0.02

(0.14)

0.06

(0.17)

(0.15)

Diluted profit (loss) per share discontinued operations

(0.15)

0.02

(0.14)

0.06

(0.17)

(0.15)

* Convenience translation into US$ (exchange rate as at December 31, 2023: euro 1 = US$ 1.106)

** The results of the Talmei Yosef PV Plant have been reclassified as discontinued operations and the results for these periods have been adjusted accordingly.

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity




Attributable to shareholders of the Company

Non- controlling

Total



Interests

Equity

Share capital

Share premium

Accumulated Deficit

Treasury shares

Translation reserve from

foreign operations

Hedging Reserve

Interests Transaction reserve with

non-controlling Interests

Total



in thousands

For the year ended











December 31, 2023 (unaudited):











Balance as at January 1, 2023

25,613

86,038

(7,256)

(1,736)

7,970

(20,602)

5,697

95,724

(12,647)

83,077

Profit (loss) for the year

-

-

2,219

-

-

-

-

2,219

(1,594)

625

Other comprehensive loss for the year

-

-

-

-

(7,585)

-

-

(7,585)

(364)

(7,949)

Total comprehensive loss for the year

-

-

2,219

-

(7,585)

-

-

(5,366)

(1,958)

(7,324)

Net change in fair value of cash flow hedges

-

-

-

-

-

24,516

-

24,516

24,709

49,225

Transactions with owners of the Company,
recognized directly in equity:











Share-based payments

-

121

-

-

-

-

-

121

-

121

Balance as at December 31, 2023

25,613

86,159

(5,037)

(1,736)

385

3,914

5,697

114,995

10,104

125,099












For the three months











ended December 31, 2023 (unaudited):











Balance as at September 30, 2023

25,613

86,131

3,453

(1,736)

(801)

(72)

5,697

118,285

6,902

125,187

Profit (loss) for the period

-

-

(8,490)

-

-

-

-

(8,490)

(1,325)

(9,815)

Other comprehensive income (loss) for the period

-

-

-

-

1,186

-

-

1,186

48

1,234

Total comprehensive income (loss) for the period

-

-

(8,490)

-

1,186

-

-

(7,304)

(1,277)

(8,581)

Net change in fair value of cash flow hedges

-

-

-

-

-

3,986

-

3,986

4,479

8,465

Transactions with owners of the Company,
recognized directly in equity:











Share-based payments

-

28

-

-

-

-

-

28

-

28

Balance as at December 31, 2023

25,613

86,159

(5,037)

(1,736)

385

3,914

5,697

114,995

10,104

125,099

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (cont'd)




Attributable to shareholders of the Company

Non- controlling

Total



Interests

Equity

Share capital

Share premium

Accumulated
Deficit

Treasury shares

Translation reserve from

foreign operations

Hedging Reserve

Interests Transaction reserve with

non-controlling Interests

Total



in thousands

For the year ended











December 31, 2022 (unaudited):











Balance as at January 1, 2022

25,605

85,883

(6,899)

(1,736)

15,365

(8,077)

5,697

115,838

(1,731)

114,107

Profit (loss) for the year

-

-

(357)

-

-

-

-

(357)

497

140

Other comprehensive loss for the year

-

-

-

-

(7,395)

-

-

(7,395)

(434)

(7,829)

Total comprehensive loss for the year

-

-

(357)

-

(7,395)

-

-

(7,752)

63

(7,689)

Net change in fair value of cash flow hedges

-

-

-

-

-

(12,525)

-

(12,525)

(14,937)

(27,462)

Transactions with owners of the Company,
recognized directly in equity:











Issuance of Capital note to non-controlling interest

-

-

-

-

-

-

-

-

3,958

3,958

Options exercise

8

28

-

-

-

-

-

36

-

36

Share-based payments

-

127

-

-

-

-

-

127

-

127

Balance as at December 31, 2022

25,613

86,038

(7,256)

(1,736)

7,970

(20,602)

5,697

95,724

(12,647)

83,077












For the three months











ended December 31, 2022 (unaudited):











Balance as at September 30, 2022

25,605

85,973

(10,685)

(1,736)

16,517

(38,731)

5,697

82,640

(28,615)

54,025

Profit (loss) for the period

-

-

3,429

-

-

-

-

3,429

(953)

2,476

Other comprehensive income (loss) for the period

-

-

-

-

(8,547)

-

-

(8,547)

(488)

(9,035)

Total comprehensive income (loss) for the period

-

-

3,429

-

(8,547)


-

(5,118)

(1,441)

(6,559)

Net change in fair value of cash flow hedges

-

-

-

-

-

18,129

-

18,129

17,409

35,538

Transactions with owners of the Company,
recognized directly in equity:











Options exercise

8

28

-

-

-

-

-

36

-

36

Share-based payments

-

37

-

-

-

-

-

37

-

37

Balance as at December 31, 2022

25,613

86,038

(7,256)

(1,736)

7,970

(20,602)

5,697

95,724

(12,647)

83,077

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (cont'd)




Attributable to shareholders of the Company

Non- controlling

Total



Interests

Equity

Share capital

Share premium

Accumulated Deficit

Treasury shares

Translation reserve from

foreign operations

Hedging Reserve

Interests Transaction reserve with

non-controlling Interests

Total



Convenience translation into US$ (exchange rate as at December 31, 2023: euro 1 = US$ 1.106)

For the year ended











December 31, 2023 (unaudited):











Balance as at January 1, 2023

28,329

95,161

(8,027)

(1,920)

8,816

(22,787)

6,301

105,873

(13,988)

91,885

Profit (loss) for the year

-

-

2,456

-

-

-

-

2,456

(1,763)

693

Other comprehensive loss for the year

-

-

-

-

(8,389)

-

-

(8,389)

(403)

(8,792)

Total comprehensive loss for the year

-

-

2,456

-

(8,389)

-

-

(5,933)

(2,166)

(8,099)

Net change in fair value of cash flow hedges

-

-

-

-

-

27,115

-

27,115

27,329

54,444

Transactions with owners of the Company,
recognized directly in equity:











Share-based payments

-

134

-

-

-

-

-

134

-

134

Balance as at December 31, 2023

28,329

95,295

(5,571)

(1,920)

427

4,328

6,301

127,189

11,175

138,364












For the three months











ended December 31, 2023 (unaudited):











Balance as at September 30, 2023

28,329

95,264

3,819

(1,920)

(885)

(81)

6,301

130,827

7,632

138,459

Profit (loss) for the period

-

-

(9,390)

-

-

-

-

(9,390)

(1,464)

(10,854)

Other comprehensive income (loss) for the period

-

-

-

-

1,312

-

-

1,312

53

1,365

Total comprehensive income (loss) for the period

-

-

(9,390)

-

1,312

-

-

(8,078)

(1,411)

(9,489)

Net change in fair value of cash flow hedges

-

-

-

-

-

4,409

-

4,409

4,954

9,363

Transactions with owners of the Company,
recognized directly in equity:











Share-based payments

-

31

-

-

-

-

-

31

-

31

Balance as at December 31, 2023

28,329

95,295

(5,571)

(1,920)

427

4,328

6,301

127,189

11,175

138,364

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Cash Flow


For the three months ended December 31,

For the year ended
December 31,

For the three months ended December 31,

For the year ended December 31,

2023

2022

2023

2022

2023

2023

Unaudited

Unaudited

Audited

Unaudited

€ in thousands

Convenience Translation into US$*

Cash flows from operating activities







Profit (loss) for the period

(9,815)

2,476

625

140

(10,854)

693

Adjustments for :







Financing expenses (income), net

3,632

(5,275)

3,034

2,466

4,016

3,355

Impairment losses on assets of disposal
groups classified as held-for-sale

2,565

-

2,565

-

2,837

2,837

Depreciation and amortization

4,378

4,241

16,473

16,092

4,842

18,220

Share-based payment transactions

28

37

121

127

31

134

Share of profit (loss) of equity accounted investees

279

(650)

(4,320)

(1,206)

309

(4,778)

Payment of interest on loan from an equity accounted investee

33

-

1,501

-

36

1,660

Change in trade receivables and other receivables

133

441

1,148

724

147

1,270

Change in other assets

69

(99)

(681)

(209)

76

(753)

Change in receivables from concessions project

259

(48)

1,778

(521)

286

1,967

Change in trade payables

(332)

2,451

(45)

1,697

(367)

(50)

Change in other payables

(2,820)

(591)

(2,563)

3,807

(3,119)

(2,835)

Income tax expense (tax benefit)

(1,391)

153

(1,852)

2,103

(1,538)

(2,048)

Income taxes paid

(473)

(1,938)

(912)

(6,337)

(523)

(1,009)

Interest received

524

493

2,936

1,896

580

3,247

Interest paid

(4,132)

(4,275)

(10,082)

(9,459)

(4,570)

(11,151)


2,752

(5,060)

9,101

11,180

3,043

10,066

Net cash from (used in) operating activities

(7,063)

(2,584)

9,726

11,320

(7,811)

10,759

Cash flows from investing activities







Acquisition of fixed assets

(9,648)

(9,543)

(61,131)

(48,610)

(10,671)

(67,613)

Repayment of loan to an equity accounted investee

1,221

-

1,324

149

1,350

1,464

Loan to an equity accounted investee

(60)

(68)

(128)

(128)

(66)

(142)

Advances on account of investments

-

(774)

(421)

(774)

-

(466)

Proceeds from advances on account of investments

297

-

2,218

-

328

2,453

Proceeds (investment) in marketable securities

-

(1,062)

2,837

(1,062)

-

3,138

Investment in settlement of derivatives, net

-

-

-

(528)

-

-

Proceed from (investment in) restricted cash, net

(53)

4,007

840

(4,873)

(59)

929

Proceeds from (investment in) short term deposit

-

-

(1,092)

27,645

-

(1,208)

Net cash used in investing activities

(8,243)

(7,440)

(55,553)

(28,181)

(9,118)

(61,445)

Cash flows from financing activities







Proceeds from options

-

36

-

36

-

-

Cost associated with long term loans

(690)

-

(1,877)

(9,988)

(763)

(2,076)

Payment of principal of lease liabilities

(190)

(155)

(1,156)

(5,703)

(210)

(1,279)

Proceeds from long-term loans

10,787

19,011

32,157

215,170

11,931

35,567

Repayment of long-term loans

(5,746)

(5,308)

(12,736)

(153,751)

(6,355)

(14,087)

Repayment of debentures

-

-

(17,763)

(19,764)

-

(19,647)

Repayment of SWAP instrument associated with long term loans

-

-

-

(3,290)

-

-

Proceed from settlement of derivatives, net

-

-

-

3,800

-

-

Proceeds from issuance of debentures, net

-

-

55,808

-

-

61,726

Net cash from financing activities

4,161

13,584

54,433

26,510

4,603

60,204

Effect of exchange rate fluctuations on cash and cash equivalents

601

(5,589)

(3,509)

(4,420)

663

(3,881)

Increase (decrease) in cash and cash equivalents

(10,544)

(2,029)

5,097

5,229

(11,663)

5,637

Cash and cash equivalents at the beginning of year

62,099

48,487

46,458

41,229

68,684

51,384

Cash from disposal groups classified as held-for-sale

(428)

-

(428)

-

(473)

(473)

Cash and cash equivalents at the end of the period

51,127

46,458

51,127

46,458

56,548

56,548

* Convenience translation into US$ (exchange rate as at December 31, 2023: euro 1 = US$ 1.106)



Ellomay Capital Ltd. and its Subsidiaries

Operating Segments


PV




Total





Ellomay




Bio



reportable


Total

Italy

Spain

Solar

Talasol

USA

Israel

Gas

Dorad

Manara

segments

Reconciliations

consolidated

For the year ended December 31, 2023

€ in thousands














Revenues

-

2,791

4,051

24,971

-

-

17,021

63,973

-

112,807

(63,973)

48,834

Operating expenses

-

(517)

(1,825)

(5,786)

-

-

(14,733)

(47,322)

-

(70,183)

47,322

(22,861)

Depreciation expenses

(1)

(912)

(946)

(11,459)

-

-

(2,670)

(5,689)

-

(21,677)

5,665

(16,012)

Gross profit (loss)

(1)

1,362

1,280

7,726

-

-

(382)

10,962

-

20,947

(10,986)

9,961














Project development costs












(4,465)

General and administrative expenses












(5,283)

Share of loss of equity accounted investee












4,320

Operating profit












4,533

Financing income












8,747

Financing expenses in connection













with derivatives and warrants, net












251

Financing expenses in connection with projects finance












(6,077)

Financing expenses in connection with debentures












(3,876)

Interest expenses on minority shareholder loan












(2,014)

Other financing expenses












(588)

Financing expenses, net












(3,557)

Loss before taxes on income












976














Segment assets as at December 31, 2023

40,054

12,807

18,666

231,142

6,267

28,297

31,164

97,339

169,783

635,519

(22,667)

612,852

Ellomay Capital Ltd. and its Subsidiaries

Reconciliation of Profit (Loss) to EBITDA (Loss)


For the three months ended December 31,

For the year ended
December 31,

For the three months
ended December 31,

For the year ended December 31,

2023

2022

2023

2022

2023

2023

in thousands

Convenience Translation into US$*

Net profit (loss) for the period

(9,815)

2,476

625

140

(10,854)

2,669

Financing expenses, net

3,832

**(4,998)

3,557

**3,476

4,237

3,933

Taxes on income (tax benefit)

(799)

**95

(1,436)

**1,652

(884)

(1,588)

Depreciation and amortization expenses

4,265

**4,115

16,012

**15,580

4,717

17,710

EBITDA (loss)

(2,517)

1,688

18,758

20,848

(2,784)

22,724

* Convenience translation into US$ (exchange rate as at December 31, 2023: euro 1 = US$ 1.106)

** The results of the Talmei Yosef PV Plant have been reclassified as discontinued operations and the results for these periods have been adjusted accordingly.

Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holder

Financial Covenants

Pursuant to the Deeds of Trust governing the Company's Series C, Series D, Series E and Series F Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 7, 2023, and below.

Net Financial Debt

As of December 31, 2023, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately €89.6 million (consisting of approximately €299.82 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €141.73 million in connection with the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021), the Series D Convertible Debentures issuance (in February 2021) and the Series E Secured Debentures issuance (in February 2023), net of approximately €52.1 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €299.84 million of project finance and related hedging transactions of the Company's subsidiaries). The Series F Debentures were issued in January 2024, therefore the results of their issuance are not included in the calculation of the financial covenants as of December 31, 2023.

Information for the Company's Series C Debenture Holders.

The Deed of Trust governing the Company's Series C Debentures (as amended on June 6, 2022, the "Series C Deed of Trust"), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of December 31, 2023, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series C Deed of Trust) was approximately €120.8 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 42.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA5, was 4.2.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended December 31, 2023:


For the four-quarter period ended December 31, 2023

Unaudited

in thousands

Profit for the period

625

Financing expenses, net

3,557

Tax benefit

(1,436)

Depreciation and amortization expenses

16,012

Share-based payments

121

Adjustment to revenues of the Talmei Yosef PV Plant
due to calculation based on the fixed asset model

2,463

Adjusted EBITDA as defined the Series C Deed of Trust

21,342

Information for the Company's Series D Debenture Holders

The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of December 31, 2023, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €120.8 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 42.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA6 was 4.2.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended December 31, 2023:


For the four-quarter period
ended December 31, 2023

Unaudited

in thousands

Profit for the period

625

Financing expenses, net

3,557

Tax benefit

(1,436)

Depreciation and amortization expenses

16,012

Share-based payments

121

Adjustment to revenues of the Talmei Yosef PV Plant
due to calculation based on the fixed asset model

2,463

Adjusted EBITDA as defined the Series D Deed of Trust

21,342

Information for the Company's Series E Debenture Holders

The Deed of Trust governing the Company's Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of December 31, 2023, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series E Deed of Trust) was approximately €120.8 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 42.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA7 was 4.2.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended December 31, 2023:


For the four-quarter period
ended December 31, 2023

Unaudited

in thousands

Profit for the period

625

Financing expenses, net

3,557

Tax benefit

(1,436)

Depreciation and amortization expenses

16,012

Share-based payments

121

Adjustment to revenues of the Talmei Yosef PV Plant
due to calculation based on the fixed asset model

2,463

Adjusted EBITDA as defined the Series E Deed of Trust

21,342

In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. ("Ellomay Luzon Energy")), which were pledged to the holders of the Company's Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.

As of December 31, 2023, the value of the assets pledged to the holders of the Series E Debentures in the Company's books (unaudited) is approximately €31.7 million (approximately NIS127.2 million based on the exchange rate as of such date)

Information for the Company's Series F Debenture Holders

The Deed of Trust governing the Company's Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of December 31, 2023, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series F Deed of Trust) was approximately €120.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 42.7%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA8 was 4.2.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series F Deed of Trust) for the four-quarter period ended December 31, 2023:


For the four-quarter period
ended December 31, 2023

Unaudited

in thousands

Profit for the period

625

Financing expenses, net

3,557

Tax benefit

(1,436)

Depreciation and amortization expenses

16,012

Share-based payments

121

Adjustment to revenues of the Talmei Yosef PV Plant
due to calculation based on the fixed asset model

2,463

Adjusted EBITDA as defined the Series F Deed of Trust

21,342

  1. The revenues presented in the Company's financial results included in this press release are based on IFRS and do not take into account the adjustments included in the Company's investor presentation.
  2. The amount of short-term and long-term debt from banks and other interest-bearing financial obligations provided above, includes an amount of approximately €4.7 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company's balance sheet.
  3. The amount of the debentures provided above includes an amount of approximately €1.6 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company's balance sheet. The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).
  4. The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
  5. The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
  6. The term "Adjusted EBITDA" is defined in the Series E Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series E Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series E Deed of Trust). The Series E Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series E Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
  7. The term "Adjusted EBITDA" is defined in the Series F Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series F Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series F Deed of Trust). The Series F Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series F Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."

SOURCE Ellomay Capital Ltd.

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.